True Wealth Design, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1966033 AKRON, OH

Position in REGN

as of Mar 31, 2026 · filed Apr 13, 2026 Compact

Position Value

$169,208

+$43,394 QoQ

Shares Held

219

+34.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

True Wealth Design, LLC holds $1,083,380 across 153 Biotechnology names. REGN ranks #2 (15.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,833	$172,521
2	REGN	Regeneron Pharmaceuticals, Inc. This page	219	$169,208
3	EXEL	Exelixis, Inc.	3,021	$129,570
4	BMRN	Biomarin Pharmaceutical Inc	1,652	$93,321
5	RPRX	Royalty Pharma plc	1,503	$72,098
6	JAZZ	Jazz Pharmaceuticals plc	200	$37,810
7	AXSM	Axsome Therapeutics, Inc.	182	$30,761
8	ALNY	Alnylam Pharmaceuticals, Inc.	76	$25,146

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$169,208	219	+34.4%	Shares	Sole	2026-04-13
2025-12-31	$125,814	163	+30.4%	Shares	Sole	2026-01-08
2025-09-30	$70,283	125	+1685.7%	Shares	Sole	2025-10-21
2025-06-30	$3,675	7	-41.7%	Shares	Sole	2025-08-06
2025-03-31	$7,610	12	+500.0%	Shares	Sole	2025-05-13
2024-12-31	$1,424	2	-33.3%	Shares	Sole	2025-02-14
2024-09-30	$3,153	3	0.0%	Shares	Sole	2024-11-14
2024-06-30	$3,153	3	+50.0%	Shares	Sole	2024-08-14
2024-03-31	$1,924	2	+100.0%	Shares	Sole	2024-05-14
2023-12-31	$878	1	-50.0%	Shares	Sole	2024-02-14
2023-09-30	$1,645	2	0.0%	Shares	Sole	2023-11-13
2023-06-30	$1,437	2	0.0%	Shares	Sole	2023-08-14
2023-03-31	$1,643	2	-99.8%	Shares	Sole	2023-05-12
2022-12-31	$814,562	1,129	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.